Payment, Coverage, and Health Economics of SGLT2 Inhibitors.

Ngoc-Yen T Pham, Christos P Argyropoulos, Sireesha Koppula

Journal: Kidney360 2022;2(6):1031-1035

PMID: 35373081

Free Full Text on PubMed Central View on PubMed

Abstract

Address: Pharmacy Department, University of New Mexico Hospitals, Albuquerque, New Mexico.; Department of Internal Medicine, Division of Nephrology, University of New Mexico School of Medicine, Albuquerque, New Mexico.

DOI: 10.34067/KID.0000742021

Link outs

Free resources

Full Text Sources:

https://pmc.ncbi.nlm.nih.gov/articles/pmid/3537308...
https://europepmc.org/abstract/MED/35373081
https://doi.org/10.34067/KID.0000742021

Medical:

https://medlineplus.gov/diabetickidneyproblems.htm...

Subscription / membership required

Full Text Sources:

http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=linko...

MeSH Terms: Diabetic Nephropathies, Humans, Sodium-Glucose Transporter 2, Sodium-Glucose Transporter 2 Inhibitors